Behavioral Science Research Unit
New York, 10025, United States
NCT Number: NCT00249587
The purpose of this study is to develop and pilot test a combined behavioral and pharmacological intervention designed to decrease pain, functional interference, and drug abuse while increasing medication adherence.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 1 / Phase 2
New York, 10025, United States
Project Pain is a Stage I behavioral therapies development project aimed at developing and pilot testing a novel intervention for patients with chronic non-malignant pain who have experienced difficulty managing prescribed opioids. The goals of the study are to: (1) develop the intervention and training materials; (2) develop therapist adherence and competence scales; (3) train therapists to deliver the intervention per the treatment protocol; and (4) pilot the intervention to assess its feasibility, acceptability and promise. The goals of the intervention are to: (1) improve adherence to prescribed opioids; (2) decrease the severity of patients' pain; and (3) improve patients' functioning and quality of life .
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
dosed to effect, every six hours
Time frame: 24 weeks
Time frame: 24 weeks
Time frame: 12 weeks
Time frame: 12 weeks
National Institute on Drug Abuse (NIDA)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07241780
Agnosia, Chronic Disease
Gümüşhane, Turkey (Türkiye)
View Trial DetailsNCT02922439
Behavior, Behavioral Symptoms
Fort Lauderdale, Florida, United States
View Trial DetailsNCT02655354
Alcohol-Related Disorders, Behavior
Scottsdale, Arizona, United States
View Trial DetailsNCT00129480
Behavior, Behavioral Symptoms
Portland, Oregon, United States
View Trial Details